BenzingaOctober 26, 2026 at 7:25 AM NYYesterday
Stifel Maintains Buy on Boston Scientific, Lowers Price Target to $55
Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $55.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
